BIEL — BioElectronics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $7.41m
- $20.75m
- $1.61m
Annual cashflow statement for BioElectronics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | — | — | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.12 | -2.99 | -2.33 | -1.16 | -0.29 |
| Depreciation | |||||
| Non-Cash Items | 0.806 | 1.09 | 0.959 | 0.416 | 0.249 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.441 | 0.54 | 0.65 | 0.216 | -0.279 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.869 | -1.35 | -0.716 | -0.528 | -0.32 |
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | — | — | — | — |
| Financing Cash Flow Items | -0.011 | -0.044 | 0 | -0.132 | -0.112 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.872 | 1.44 | 0.669 | 0.591 | 0.212 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.003 | 0.084 | -0.047 | 0.063 | -0.109 |